IDEX (NYSE:IEX) Announces Earnings Results, Beats Estimates By $0.22 EPS

Key Points

• IDEX beat Q1 expectations, reporting $2.00 EPS vs. $1.78 expected and $886.9M revenue (vs. $845.8M), and raised guidance to $2.07–$2.12 for Q2 and $8.35–$8.55 for FY2026 while organic sales were up 5% and adjusted EBITDA margin improved to 26%.
• Segment divergence: Health & Science Technologies outperformed with orders +17%, organic revenue +11% and 100 bps margin expansion plus a stronger backlog tied to AI/data‑center and semiconductor end markets, while short‑cycle segments FMT and FSDP showed tepid or negative growth.
• Management repurchased $76M of stock in Q1, generated $86M FCF, maintained ~2x gross leverage and an active bolt‑on M&A pipeline, and the stock jumped ~5.6% amid analyst targets skewing positive (consensus "Moderate Buy", average target ≈ $228.90 / median near $241).

IDEX (NYSE:IEX - Get Free Report) released its earnings results on Wednesday. The industrial products company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.78 by $0.22, FiscalAI reports. IDEX had a return on equity of 15.03% and a net margin of 13.98%.The firm had revenue of $886.90 million during the quarter, compared to analysts' expectations of $845.75 million. During the same period in the previous year, the firm posted $1.75 EPS. IDEX's revenue for the quarter was up 8.9% on a year-over-year basis. IDEX updated its Q2 2026 guidance to 2.070-2.120 EPS and its FY 2026 guidance to 8.350-8.550 EPS.

Here are the key takeaways from IDEX's conference call:

• Q1 beat and guidance raised: IDEX reported organic sales up 5%, Adjusted EBITDA margin of 26% (+50 bps YoY) and orders +10% organically, and raised full‑year organic growth to 3%–4% with Adjusted EPS now $8.35–$8.55.
• HST outperformance and backlog build: Health & Science Technologies drove momentum with orders +17% and organic revenue +11%, 100 bps margin expansion and a stronger backlog that management says increases visibility into growth into 2027 across data center, semiconductor and space & defense markets.
• Mixed performance in short‑cycle segments — FMT and FSDP lagging: FMT orders were +9% but sales only +2% (margin down 10 bps) and FSDP orders fell 4% with sales down 1%; management is forecasting flattish growth for these segments, which limits near‑term consolidated upside.
• Capital allocation and liquidity intact: IDEX repurchased $76M of stock in Q1 (plans to maintain quarterly pace), generated $86M FCF in the seasonally weak quarter, finished with ~2x gross leverage and an active bolt‑on M&A pipeline while keeping buybacks and dividends.

IDEX Trading Up 5.6%

NYSE:IEX opened at $216.90 on Thursday. IDEX has a 1 year low of $157.25 and a 1 year high of $223.85. The stock has a market cap of $16.13 billion, a P/E ratio of 33.84, a P/E/G ratio of 2.10 and a beta of 0.99. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.02 and a current ratio of 2.86. The stock has a 50-day simple moving average of $198.78 and a 200-day simple moving average of $187.55.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of IEX. Empowered Funds LLC lifted its position in IDEX by 3.4% in the first quarter. Empowered Funds LLC now owns 1,646 shares of the industrial products company's stock valued at $298,000 after acquiring an additional 54 shares during the last quarter. Mackenzie Financial Corp grew its holdings in shares of IDEX by 2.8% during the fourth quarter. Mackenzie Financial Corp now owns 2,562 shares of the industrial products company's stock worth $458,000 after purchasing an additional 70 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of IDEX by 18.6% during the third quarter. Parallel Advisors LLC now owns 664 shares of the industrial products company's stock worth $108,000 after purchasing an additional 104 shares during the last quarter. Benjamin Edwards Inc. increased its position in shares of IDEX by 9.6% during the second quarter. Benjamin Edwards Inc. now owns 1,403 shares of the industrial products company's stock worth $246,000 after purchasing an additional 123 shares in the last quarter. Finally, Commerce Bank increased its position in shares of IDEX by 5.1% during the fourth quarter. Commerce Bank now owns 2,611 shares of the industrial products company's stock worth $465,000 after purchasing an additional 126 shares in the last quarter. Institutional investors and hedge funds own 97.96% of the company's stock.

Analysts Set New Price Targets

IEX has been the subject of several recent research reports. BMO Capital Markets began coverage on IDEX in a research note on Friday, March 27th. They issued a "market perform" rating and a $214.00 price objective for the company. Robert W. Baird set a $247.00 target price on shares of IDEX in a research note on Thursday, February 5th. TD Cowen raised their target price on shares of IDEX from $200.00 to $250.00 and gave the company a "buy" rating in a report on Thursday, February 5th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of IDEX in a report on Monday, April 20th. Finally, Stifel Nicolaus decreased their price target on shares of IDEX from $244.00 to $241.00 and set a "buy" rating for the company in a research note on Tuesday, April 14th. Six analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $228.90.

Key IDEX News

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: IDEX beat Q1 estimates and raised guidance — Q1 revenue was $886.9M (≈ +8.9% YoY) and adjusted diluted EPS was $2.00, topping expectations; management raised FY 2026 adjusted EPS guidance to $8.35–8.55 (above consensus) and gave Q2 EPS guidance of $2.07–2.12, which frames near‑term momentum. Read More.
• Positive Sentiment: Management cited strong AI/data‑center demand — Reuters highlights that elevated demand from AI and data‑center customers helped justify the higher profit forecast, a secular tailwind that can sustain higher margins and growth. Read More.
• Positive Sentiment: Analyst targets and sentiment skew positive — recent analyst coverage shows multiple price targets above the current level (median near $241), implying upside if execution continues. That supportive research likely amplified investor buying after the beat. Read More.
• Neutral Sentiment: Earnings call / transcript available for deeper color — the investor presentation and call transcript give more detail on end‑market demand, backlog, and margin drivers for active investors wanting to verify sustainability of the beat. Read More.
• Neutral Sentiment: Market activity and technicals — intraday volume is running above average and the stock is trading above both its 50‑ and 200‑day moving averages, which can attract momentum flows; monitor volume if you’re timing entries/exits. Read More.
• Negative Sentiment: Institutional position shifts are mixed — while many funds hold IEX, some large managers reduced exposure heavily in the prior quarter (e.g., UBS AM), a sign that some large holders may take profits or rebalance into other themes. This could limit upside if selling resumes. Read More.

About IDEX

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company's core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.